| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Endo International plc (NASDAQ: ENDP)
ENDP Technical Analysis
5
| As on 1st Jul 2022 ENDP Share Price closed @ 0.57 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.53 & Strong Sell for SHORT-TERM with Stoploss of 8.16 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ENDP Share Price
| Open | 0.40 | Change | Price | % |
| High | 0.62 | 1 Day | 0.10 | 21.28 |
| Low | 0.37 | 1 Week | 0.21 | 58.33 |
| Close | 0.57 | 1 Month | -0.05 | -8.06 |
| Volume | 199580740 | 1 Year | -6.55 | -91.99 |
| 52 Week High 10.55 | 52 Week Low 0.30 | ||||
NASDAQ USA Most Active Stocks
| ENDP | 0.57 | 21.28% |
| ALNA | 0.21 | 10.53% |
| XELA | 0.11 | 0.00% |
| AMD | 73.67 | -3.66% |
| CLVS | 2.85 | 58.33% |
| AKBA | 0.39 | 11.43% |
| AMZN | 109.56 | 3.15% |
| AAPL | 138.93 | 1.62% |
| NVDA | 145.23 | -4.20% |
| AGRX | 0.64 | -45.30% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ENDP Daily Charts |
ENDP Intraday Charts |
Whats New @ Bazaartrend |
ENDP Free Analysis |
|
|
ENDP Important Levels Intraday
| RESISTANCE | 1.05 |
| RESISTANCE | 0.90 |
| RESISTANCE | 0.80 |
| RESISTANCE | 0.71 |
| SUPPORT | 0.43 |
| SUPPORT | 0.34 |
| SUPPORT | 0.24 |
| SUPPORT | 0.09 |
ENDP Target for Month July
| 4th UP TARGET | 8.76 |
| 3rd UP TARGET | 6.13 |
| 2nd UP TARGET | 4.51 |
| 1st UP TARGET | 2.89 |
| 1st DOWN TARGET | -1.75 |
| 2nd DOWN TARGET | -3.37 |
| 3rd DOWN TARGET | -4.99 |
| 4th DOWN TARGET | -7.62 |
ENDP Weekly Target
| 4th UP TARGET | 2.00 |
| 3rd UP TARGET | 1.54 |
| 2nd UP TARGET | 1.26 |
| 1st UP TARGET | 0.97 |
| 1st DOWN TARGET | 0.17 |
| 2nd DOWN TARGET | -0.12 |
| 3rd DOWN TARGET | -0.40 |
| 4th DOWN TARGET | -0.86 |
ENDP Target for Year 2022
| 4th UP TARGET | 21.02 |
| 3rd UP TARGET | 14.46 |
| 2nd UP TARGET | 10.41 |
| 1st UP TARGET | 6.35 |
| 1st DOWN TARGET | -5.21 |
| 2nd DOWN TARGET | -9.27 |
| 3rd DOWN TARGET | -13.32 |
| 4th DOWN TARGET | -19.88 |
Endo International plc ( NASDAQ USA Symbol : ENDP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ENDP Business Profile
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. Address: Minerva House, Dublin, Ireland, 4
© 2005-2021 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service